APA (7th ed.) Citation

Yi, J. H., Lee, J. H., Jung, S., Lee, J. H., Lee, J. Y., Kim, K., . . . Yoon, D. H. (2026). Real-World Efficacy and Safety of Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma: Nationwide Retrospective Analysis of the Named Patient Program in Korea. Cancer Research & Treatment, 58(3), 971. https://doi.org/10.4143/crt.2025.399

Chicago Style (17th ed.) Citation

Yi, Jun Ho, et al. "Real-World Efficacy and Safety of Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma: Nationwide Retrospective Analysis of the Named Patient Program in Korea." Cancer Research & Treatment 58, no. 3 (2026): 971. https://doi.org/10.4143/crt.2025.399.

MLA (9th ed.) Citation

Yi, Jun Ho, et al. "Real-World Efficacy and Safety of Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma: Nationwide Retrospective Analysis of the Named Patient Program in Korea." Cancer Research & Treatment, vol. 58, no. 3, 2026, p. 971, https://doi.org/10.4143/crt.2025.399.